URMC Logo

URMC / Research / Research@URMC
Potential New Parkinson’s Treatment Passes Hurdle

Potential New Parkinson’s Treatment Passes Hurdle

A Phase 2 clinical trial of the nutritional supplement inosine has shown that the compound can safely and effectively raise levels of urate, a naturally occurring compound found in blood. Scientists suspect that urate may slow the progression of Parkinson’s disease. 

12/23/2013 | 1 comment
Batten Researchers Converge on Rochester

Batten Researchers Converge on Rochester

With incredibly rare diseases like Juvenile Batten Disease, the road map for moving research from the lab to patients is often unclear. This week, researchers, parents and representatives of advocacy groups from across the United States and Europe convene at the Medical Center to discuss the future of clinical trials for this devastating disorder. 

12/5/2013 | 0 comments
Destination Infection: How Immune Cells Move Through the Body

Destination Infection: How Immune Cells Move Through the Body

In a recent study in Nature Immunology, Deborah Fowell, Ph.D., associate professor of Microbiology and Immunology, mapped how immune cells travel to sites of injury or infection. She says the findings could help with the development of treatments that stop, slow down or speed up the immune response.  Check out this video of Fowell for more details on her work. 

8/21/2013 | 0 comments
URMC Heart Research Expands to Asia

URMC Heart Research Expands to Asia

Cardiologists at the University of Rochester Medical Center are launching a new study in an effort to improve the treatment of a very common form of heart disease in the Asian population. 

8/6/2013 | 1 comment
Unraveling the Origins of Congenital Heart Disease

Unraveling the Origins of Congenital Heart Disease

In a first-of-its-kind study published in the journal Nature, scientists identified a group of gene mutations that may be behind up to 10 percent of complex congenital heart defects, the most frequent birth defect and a leading cause of infant death.

7/23/2013 | 0 comments
12